Immunoassays News and Research

RSS

Lateral flow assays detect a compound of interest in a compact, paper-based system. Tests such as pregnancy tests are based on lateral flow assays, with many more available for various compounds or even pathogens.

Veravas launches advanced solutions to address biotin interference in diagnostic tests

Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.

12 Jul 2019

PerkinElmer unveils CE-marked infectious disease immunoassays on EUROIMMUN random access instrument

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the first two CE-marked chemiluminescence immunoassays (ChLIA) for the detection of anti-Borrelia (Lyme disease) and anti-EBV/EBNA (Epstein-Barr Virus) antibodies on its EUROIMMUN RA Analyzer 10 system.

From Revvity 11 Jul 2019

Antibodies.com raises £400,000 in pre-seed financing to help scientists discover more for less

Antibodies.com, a digital marketplace that enables life scientists to purchase critical research reagents at cost-effective prices from the primary manufacturers, today announced that is has raised £400,000 in pre-seed financing.

From Antibodies.com 2 Jul 2019

Expedeon AG launches Lightning-Link Metal Labeling Kits to support single cell analysis

Expedeon AG announced today it has introduced Lightning-Link Metal Labeling Kits for use in multiple immunoassay-based applications to support single cell analysis.

24 Jun 2019

Expedeon announces addition of CaptSure DIY ELISA to immunoassay product portfolio

CaptSure DIY ELISA will complement Expedeon AG’s product offering, as the Company announced today. The technology was developed by TGR BioSciences, which was acquired by Expedeon in May 2018.

29 May 2019

LC-MS/MS test for progesterone outperforms traditional immunoassays

Researchers have devised a cheap, non-invasive and specific means to monitor progesterone production in women.

15 May 2019

Quanterix’ Simoa technology powers more than 85 percent of Neurofilament light biomarker research to be unveiled at American Academy of Neurology Annual Meeting

Quanterix announce that its ultra-sensitive Simoa technology is the driving force behind 36 of the 42 Nf-L abstracts being presented at AANA.

From Quanterix 6 May 2019

Expedeon signs license agreement for use of Lightning-Link technology

Expedeon AG, today announced it has signed a supply and license agreement with Cell Guidance Systems for use of Expedeon’s proprietary Lightning-Link Rapid Biotin..

9 Jan 2019

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received CE Mark to market Quidel's Sofia 2 Lyme+ FIA to be used with the Sofia 2 Fluorescent Immunoassay Analyzer for the rapid differential detection of human IgM and IgG antibodies to Borrelia burgdorferi, Borrelia garinii, and Borrelia afzelii from serum and plasma specimens.

19 Dec 2018

Answering the Biggest Neurological Research Questions of Today

An interview with Dr. Peggy Taylor, discussing the biggest neurological research questions of today and how BioLegend is helping to develop new biomarkers for neurological disease.

From BioLegend 14 Dec 2018

New immuno-assay can detect small molecules with 50-fold greater sensitivity

As medical science has come to understand that the human body is controlled on the molecular level by various proteins, hormones, drugs, and other substances, technologies have developed to detect levels of these molecules in order to monitor health and diagnose disease.

6 Dec 2018

The Native Antigen Company launches ground-breaking Zika virus immunoassays

The Native Antigen Company has launched a series of ground-breaking immunoassays for Zika virus, offering researchers in academia, public health and drug discovery the capability to work with unprecedented levels of specificity and sensitivity.

29 Nov 2018

FIND explores new diagnostic assays for confirmatory HCV diagnosis in community settings

The Foundation for Innovative New Diagnostics today announced awards to support the development, manufacture and feasibility testing of two prototype hepatitis C virus core antigen immunoassays for confirmatory HCV diagnosis at the point of care.

16 Nov 2018

Roche receives Breakthrough Device Designation from FDA for new Alzheimer's disease assays

Roche announced today, that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to Elecsys ß-Amyloid (1-42) CSF and Elecsys Phospho-Tau (181P) CSF.

From Roche Sequencing and Life Science 24 Jul 2018

Synthetic cannabis use may increase risk of heart attack and stroke

The warning follows their treatment of a 25 year old prison inmate who had no family history of heart disease or traditional cardiovascular risk factors, and who was left with a permanent disability.

8 Jun 2018

New analytical method improves diagnosis and monitoring of cancer

Ten times more sensitive than current techniques, the technique allows, from a blood serum sample, to simultaneously detect different biomarkers related to cancer.

8 Jun 2018

New case report reveals negative clinical impact of using biotin supplement

A new case report in the Journal of the Endocrine Society documents how a patient's use of a common biotin supplement, also known as vitamin B7, caused her to have clinically misleading test results, which prompted numerous consultations and unnecessary radiographic and laboratory testing.

21 May 2018

AYOXXA introduces new LUNARIS Mouse 12-Plex Th17 Kit for quantitative analysis of Th17 cell biology

AYOXXA Biosystems GmbH, an international biotechnology company, focused on the development of innovative multiplex protein analysis technologies enabling translational research in basic and clinical research, today announced the expansion of its catalogue of immunoassays for multiplex protein analysis with the introduction of LUNARIS™ Mouse 12-Plex Th17 Kit for the quantitative analysis of soluble mouse T helper 17 (Th17) cell-related markers.

20 Apr 2018

AYOXXA launches advanced low-volume beads-on-a-chip multiplex protein analysis system

AYOXXA Biosystems GmbH, an international biotechnology company, today announces the introduction of its advanced low-volume beads-on-a-chip multiplex protein analysis system. The LUNARIS™ system can be readily integrated into any laboratory routine and is optimized to provide easy-to-use, standardized workflow from sample to result.

20 Apr 2018

The Neuro and Thermo Fisher Scientific team up to accelerate understanding of neurological disease

The Montreal Neurological Institute of McGill University, a world-leading institution focused on brain research and advanced patient care, and Thermo Fisher Scientific, the world leader in serving science, today announce an agreement designed to accelerate the understanding of neurological disease by focusing on about 30 proteins associated with Parkinson's disease, amyotrophic lateral sclerosis (ALS), hereditary spastic paraplegias, epileptic encephalopathies and ataxias, which are all devastating brain diseases.

5 Mar 2018

Immunoassays News and Research

Further Reading

Veravas launches advanced solutions to address biotin interference in diagnostic tests

PerkinElmer unveils CE-marked infectious disease immunoassays on EUROIMMUN random access instrument

Antibodies.com raises £400,000 in pre-seed financing to help scientists discover more for less

Expedeon AG launches Lightning-Link Metal Labeling Kits to support single cell analysis

Expedeon announces addition of CaptSure DIY ELISA to immunoassay product portfolio

LC-MS/MS test for progesterone outperforms traditional immunoassays

Quanterix’ Simoa technology powers more than 85 percent of Neurofilament light biomarker research to be unveiled at American Academy of Neurology Annual Meeting

Expedeon signs license agreement for use of Lightning-Link technology

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

Answering the Biggest Neurological Research Questions of Today

New immuno-assay can detect small molecules with 50-fold greater sensitivity

The Native Antigen Company launches ground-breaking Zika virus immunoassays

FIND explores new diagnostic assays for confirmatory HCV diagnosis in community settings

Roche receives Breakthrough Device Designation from FDA for new Alzheimer's disease assays

Synthetic cannabis use may increase risk of heart attack and stroke

New analytical method improves diagnosis and monitoring of cancer

New case report reveals negative clinical impact of using biotin supplement

AYOXXA introduces new LUNARIS Mouse 12-Plex Th17 Kit for quantitative analysis of Th17 cell biology

AYOXXA launches advanced low-volume beads-on-a-chip multiplex protein analysis system

The Neuro and Thermo Fisher Scientific team up to accelerate understanding of neurological disease

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News